NAVA.OL
Navamedic ASA
Price:  
22.50 
NOK
Volume:  
16,001.00
Norway | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NAVA.OL WACC - Weighted Average Cost of Capital

The WACC of Navamedic ASA (NAVA.OL) is 6.1%.

The Cost of Equity of Navamedic ASA (NAVA.OL) is 6.85%.
The Cost of Debt of Navamedic ASA (NAVA.OL) is 4.90%.

Range Selected
Cost of equity 5.60% - 8.10% 6.85%
Tax rate 22.00% - 22.00% 22.00%
Cost of debt 4.40% - 5.40% 4.90%
WACC 5.1% - 7.2% 6.1%
WACC

NAVA.OL WACC calculation

Category Low High
Long-term bond rate 3.3% 3.8%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.45 0.61
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.60% 8.10%
Tax rate 22.00% 22.00%
Debt/Equity ratio 0.3 0.3
Cost of debt 4.40% 5.40%
After-tax WACC 5.1% 7.2%
Selected WACC 6.1%

NAVA.OL's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for NAVA.OL:

cost_of_equity (6.85%) = risk_free_rate (3.55%) + equity_risk_premium (5.60%) * adjusted_beta (0.45) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.